Peloton Wealth Strategists raised its stake in shares of iShares iBonds Dec 2032 Term Corporate ETF (NYSEARCA:IBDX – Free Report) by 68.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 94,500 shares of the company’s stock after purchasing an additional 38,500 shares during the quarter. Peloton Wealth Strategists owned 0.15% of iShares iBonds Dec 2032 Term Corporate ETF worth $2,413,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also bought and sold shares of IBDX. Ameriprise Financial Inc. lifted its position in iShares iBonds Dec 2032 Term Corporate ETF by 111.2% during the third quarter. Ameriprise Financial Inc. now owns 1,707,594 shares of the company’s stock valued at $43,762,000 after purchasing an additional 899,251 shares during the last quarter. Confluence Investment Management LLC bought a new stake in iShares iBonds Dec 2032 Term Corporate ETF during the fourth quarter valued at approximately $7,611,000. Praetorian Wealth Management Inc. bought a new stake in iShares iBonds Dec 2032 Term Corporate ETF during the fourth quarter valued at approximately $2,205,000. Atlantic Union Bankshares Corp lifted its position in iShares iBonds Dec 2032 Term Corporate ETF by 36.8% during the fourth quarter. Atlantic Union Bankshares Corp now owns 315,958 shares of the company’s stock valued at $8,066,000 after purchasing an additional 85,012 shares during the last quarter. Finally, JPMorgan Chase & Co. bought a new stake in iShares iBonds Dec 2032 Term Corporate ETF during the third quarter valued at approximately $1,283,000.
iShares iBonds Dec 2032 Term Corporate ETF Trading Up 0.1%
Shares of iShares iBonds Dec 2032 Term Corporate ETF stock opened at $25.17 on Wednesday. iShares iBonds Dec 2032 Term Corporate ETF has a 1 year low of $24.85 and a 1 year high of $26.77. The company has a 50 day simple moving average of $25.21 and a two-hundred day simple moving average of $25.41.
About iShares iBonds Dec 2032 Term Corporate ETF
The iShares iBonds Dec 2032 Term Corporate ETF (IBDX) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg index of USD-denominated, investment grade corporate bonds maturing between January 1, 2032 and December 15, 2032. IBDX was launched on Jun 28, 2022 and is managed by BlackRock.
Recommended Stories
- Five stocks we like better than iShares iBonds Dec 2032 Term Corporate ETF
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for iShares iBonds Dec 2032 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2032 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.
